Senthil Ramaswamy has over 20 years of global leadership experience in process and product development, technology transfer, and site and operations management for the clinical and commercial manufacturing of biologics and cell and gene therapies. He is currently the Vice President of R&D and Innovation for the Cell & Gene Division at Lonza. In this role, Senthil is driving the strategic direction and advancing innovative solutions for cell and gene therapy manufacturing. Over the past 14 years at Lonza, Senthil has held positions of increasing responsibility across multiple geographies and business areas, including interim Site Head for Lonza’s commercial cell and gene therapy manufacturing site in Houston, Director of Cell Therapy Operations in Walkersville, Maryland, and Head of Biologics MSAT in Singapore. Before joining Lonza, Senthil led product development at MilliporeSigma, where he served as a Consulting Engineer and Group Leader from 2002 to 2010. He holds a Ph.D. in Chemical Engineering from the University of Colorado Boulder.